A New Jersey federal judge has ordered that a General Electric subsidiary pay $11.3 million for making false-advertising claims about a competitor's X-ray contrast agent. The judge held that Amersham Health violated the Lanham Act with false and misleading claims that its contrast agent was superior to one made by Bracco Diagnostics, and found that Bracco was entitled to reimbursement of about $8 million for past "corrective" ads and an additional $3 million that it planned to spend on future ads.
GE Unit Ordered to Pay $11.3 Million Over False-Advertising Claims Against Competitor
New Jersey Law Journal
April 14, 2009